Editorial: Should probiotics be routine therapy for the prevention of antibiotic-associated diarrhea?

Journal of Clinical Gastroenterology

Volumn 44, Issue 2, 2010, Pages 83-84

  Katz, Jeffry A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; YOGHURT; ANTIINFECTIVE AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC INDUCED DIARRHEA; ANTIBIOTIC THERAPY; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESEARCH; DRUG WITHDRAWAL; EDITORIAL; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TRANSIT; HEALTH CARE COST; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LOOSE FECES; PATIENT SAFETY; PRIORITY JOURNAL; RECTUM BIOPSY; RISK REDUCTION; SACCHAROMYCES BOULARDII; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; HUMANS; LACTOBACILLUS PLANTARUM; PROBIOTICS;

EID: 75749121858     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181bdf010     Document Type: Editorial

References (14)

1. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and probiotics: gastroenterology enters the metagenomics era. Gastroenterology. 2009;136:2015-2031.
2. Bartlett JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346:334-339.
3. Doron SI, Hibberd PL, Gorbach SL. Probiotics for the prevention of antibiotic-associated diarrhea. J Clin Gastroenterol. 2008;42: S58-S63.
4. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhea. Aliment Pharmacol Ther. 2002;16:1461-1467.
5. D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in the prevention of antibiotic associated diarrhoea: meta-analysis. BMJ. 2002;324:1361-1366.
6. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebocontrolled trials. CMAJ. 2006;175:377-383.
7. Szajewska H, Ruszczjski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006;149:367-372.
8. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of clostridium difficile disease. Am J Gastroenterol. 2006;101:812-822.
9. Johnston BC, Supina AL, Ospina M, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Syst Rev. 2007;CD004827. doi: 10.1002/14651858.
10. Lönnermark E, Friman V, Lappas G, et al. Intake of lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;44:106-112.
11. Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and clostridium difficile diarrhea. J Clin Gastroenterol. 2006;40:249-255.
12. Floch MF, Walker WA, Guandalini S, et al. Recommendations for probiotic use-2008. J Clin Gastroenterol. 2008;42(suppl 2): S104-S108.
13. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80-84.
14. Kyne L, Hamel MB, Polavaram R, et al. Health care costs and mortality associated with nosocomial diarrhea due to clostridium difficile. Clin Infect Dis. 2002;34:346-353.